// App-Quantinova.ai

TCT-522 : Outcomes of Patients Undergoing ViV TAVR With the Current-Generation Transcatheter Aortic Valves for Purely Regurgitant Surgical Bioprostheses

Researchers

Presenter

  • Radoslaw Pracon

Principal Investigators

  • Michael McGarvey

  • Aleksandar Dimitrov

  • Suzane Cadiz

  • Tito Kabir

  • Miles Dalby

  • Alison Duncan

  • S.W. Davies

  • Vasileios Panoulas

Medical Centers

  • Royal Brompton & Harefield Trust, London, United Kingdom

  • London, United Kingdom Co-Author

  • Royal Brompton & Harefield Hospitals, Guys & St Thomas NHS Foundation Trust, Harefield, United Kingdom

  • Royal Brompton & Harefield Hospitals, Guys & St Thomas NHS Foundation Trust, Harefield, United Kingdom Co-Author

  • Royal Brompton and Harefield Hospitals, part of Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved